findmyKOL
Clinical trialNCT00935961CompletedPhase 1Interventional

RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer

SponsorMemorial Sloan Kettering Cancer CenterEnrollment18HEAD & NECK Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Memorial Sloan-Kettering Cancer Center at Basking Ridge

    Basking Ridge, New Jersey, United States

  • Memorial Sloan-Kettering Cancer Center at Commack

    Commack, New York, United States

  • Memorial Sloan-Kettering Cancer Center

    New York, New York, United States

  • Memorial Sloan-Kettering at Mercy Medical Center

    Rockville Centre, New York, United States

  • Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center

    Sleepy Hollow, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2009
Primary completion
31 Aug 2013
Completion
31 Aug 2013
Last update posted
9 Aug 2013
Registered enrollment
18
Registry id
NCT00935961

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.